• CRISPR/Cas9 Knockout of ABCB1 Reverses Tumor Drug Resistance

  2026-04-29

  This study demonstrates that CRISPR/Cas9-mediated disruption of the ABCB1 gene restores chemosensitivity in multidrug-resistant (MDR) cancer cells. The findings highlight the power of genome editing for dissecting drug resistance mechanisms and suggest potential avenues for overcoming MDR in oncology research.

• Haloprogin: Precision Antifungal Profiling and Protocol Opti

  2026-04-28

  Discover how Haloprogin enables advanced, evidence-driven antifungal and antimicrobial assay design. Uncover nuanced insights into MIC/MFC profiling, protocol selection, and real-world research applications that go beyond established guidance.

• Tobramycin: Precision Applications in Microbiology Assays

  2026-04-28

  Explore the advanced use of Tobramycin, a leading aminoglycoside antibiotic, in microbiology assay design and resistance research. This article delivers new practical frameworks for optimizing antibiotic protocols, supported by benchmark comparative data.

• U 46619 (SKU B6890): Reliable Tool for Platelet and Vascular

  2026-04-27

  This authoritative guide explores how U 46619 (SKU B6890), a selective prostaglandin H2/thromboxane A2 receptor agonist, addresses common experimental challenges in platelet function and vascular biology assays. Grounded in peer-reviewed data and validated protocols, the article helps biomedical researchers achieve reproducible, quantitative results and highlights best practices for integrating U 46619 into their workflow.

• JSH-23: Precision NF-κB Inhibitor for Inflammation Research

  2026-04-27

  JSH-23 stands out as a potent small molecule NF-κB inhibitor, uniquely suited for dissecting macrophage-driven inflammatory signaling and modulating cytokine output in translational disease models. Its robust workflow flexibility, clear mechanism, and literature-backed efficacy streamline both in vitro and in vivo inflammation studies.

• Trelagliptin Succinate Enhances Insulin Signaling in Adipocy

  2026-04-26

  This study reveals that trelagliptin succinate, a DPP-4 inhibitor, improves insulin resistance in adipocytes by enhancing PI-3K/AKT/GLUT4 signaling and modulating adipokine secretion. These findings clarify trelagliptin’s molecular mechanism in glucose metabolism and provide direction for targeted metabolic disease research.

• AT-406 (SM-406): Apoptosis Pathway Activation in Cancer Rese

  2026-04-25

  Explore how AT-406 (SM-406) advances apoptosis pathway activation in cancer research, with a rigorous scientific review, unique protocol insights, and a comparative analysis versus existing IAP inhibitors.

• 3D Osteocyte Networks Respond to Pulsatile Fluid Flow via Co

  2026-04-24

  This study introduces a microfluidic platform for culturing three-dimensional osteocyte networks under pulsatile unidirectional fluid flow stimuli (PUFFS), enabling real-time observation of mechanotransduction processes. The findings demonstrate that osteocyte calcium signaling and gene expression are sustained and dynamically regulated via connexin 43-mediated gap junctions, with direct implications for mechanobiology and intercellular communication research.

• SREBP-1c Impairs ULK1 Sulfhydration and Autophagy in NAFLD

  2026-04-24

  Nguyen et al. (2021) reveal that SREBP-1c suppresses CSE/H2S signaling, thereby impairing ULK1-dependent autophagic flux and promoting hepatic steatosis in high-fat-diet-fed mice. This mechanistic insight uncovers a dual role for SREBP-1c in lipid metabolism and highlights the significance of post-translational modification analysis in liver disease research.

• ECL Western Blotting Substrate: Technical Parameters & Workf

  2026-04-23

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of HRP-labeled proteins in chemiluminescent Western blot assays. It is designed for protein analysis in molecular biology, cancer biology, and signal transduction studies, but is not suitable for fluorescent or radioisotopic workflows.

• Escitalopram (Lexapro) for Antidepressant Research: Optimize

  2026-04-23

  Escitalopram’s unmatched selectivity empowers precise antidepressant and anxiolytic activity studies in preclinical models. This guide provides advanced protocols, troubleshooting insights, and translational tips using APExBIO’s high-purity Escitalopram for robust serotonergic research.

• Geneticin (G-418 Sulfate): Beyond Selection—Mechanistic and

  2026-04-22

  Explore the multifaceted scientific utility of Geneticin (G418 Sulfate), including its unique ribosomal inhibition, antiviral potential, and implications for metabolic studies in cell biology. This article delivers mechanistic clarity and links the latest immunometabolism research to practical assay design.

• Ibotenic Acid: NMDA Receptor Agonist for Neurodegenerative M

  2026-04-22

  Ibotenic acid from APExBIO empowers researchers to reproducibly model neurodegenerative diseases and dissect neural circuits with high precision. Leveraging its robust solubility and validated receptor specificity, labs can achieve reliable and translatable outcomes in pain and neurodegeneration studies.

• GSK3 Inhibition as a Host-Directed Strategy for Tuberculosis

  2026-04-21

  This article examines a recent iScience paper demonstrating that glycogen synthase kinase 3 (GSK3) inhibition in human macrophages suppresses Mycobacterium tuberculosis (Mtb) growth. The findings suggest host-directed therapy targeting GSK3 may offer a viable alternative or adjunct to conventional antibiotic strategies, with significant implications for multi-drug resistant tuberculosis research.

• Precision Cell Surface Proteomics: Biotin-XX Tyramide’s Stra

  2026-04-21

  This thought-leadership article examines the transformative potential of Biotin-XX Tyramide Reagent (biotin-LC-LC-tyramide) in translational proteomics. It dissects the mechanistic rationale for membrane-impermeant proximity labeling, showcases recent peer-reviewed advances in synaptic protein trafficking, and delivers actionable guidance on leveraging tyramide signal amplification (TSA) for robust immunohistochemistry and in situ hybridization. By bridging molecular insight with strategic workflow recommendations, this piece sets a new benchmark for translational researchers exploring cell surface protein dynamics with unprecedented sensitivity and spatial fidelity.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page